Login
Home
Charts
Search
Watchlist
Products

Biocon Ltd

BIOCON·NSE
₹390.00-1.27%Tue, 22 Sept '26 15:56
Industry:Pharma - Formulators
Indices:

Biocon Ltd

BIOCON
NSE
₹390.00
-1.27%
|Tue, 22 Sept '26 15:56
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹63,558Cr
Close
Close Price
₹390.00
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
114.71
PS
Price To Sales
3.67
Revenue
Revenue
₹17,321Cr
Rev Gr TTM
Revenue Growth TTM
9.83%
PAT Gr TTM
PAT Growth TTM
-36.60%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3,4623,9543,9173,4333,5903,8214,4173,9424,2964,1734,5174,336
Growth YoY
Revenue Growth YoY%
49.334.43.80.33.7-3.412.814.819.69.22.310.0
Expenses
ExpensesCr
2,7213,0273,0012,8132,9053,0703,3393,1763,4603,3403,4963,489
Operating Profit
Operating ProfitCr
7429279166206857521,0787668358341,020847
OPM
OPM%
21.423.423.418.119.119.724.419.419.420.022.619.5
Other Income
Other IncomeCr
110563371,1675953576381-176-2841
Interest Expense
Interest ExpenseCr
248267227236226223212277272210232213
Depreciation
DepreciationCr
389415407405420425436455473515513547
PBT
PBTCr
2148083191,1469815648797171-68248128
Tax
TaxCr
425596284717527839-1649-9
PAT
PATCr
173753223862278145989133-52199137
Growth YoY
PAT Growth YoY%
111.13,739.1-46.2478.8-84.3-89.2106.1-89.7390.0-163.9-56.853.4
NPM
NPM%
5.019.15.725.10.82.110.42.33.1-1.24.43.1
EPS
EPS₹
1.15.51.15.5-0.10.22.90.30.71.10.80.9
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3,4623,9543,9173,4333,5903,8214,4173,9424,2964,1734,5174,336
Growth YoY
Revenue Growth YoY%
49.334.43.80.33.7-3.412.814.819.69.22.310.0
Expenses
ExpensesCr
2,7213,0273,0012,8132,9053,0703,3393,1763,4603,3403,4963,489
Operating Profit
Operating ProfitCr
7429279166206857521,0787668358341,020847
OPM
OPM%
21.423.423.418.119.119.724.419.419.420.022.619.5
Other Income
Other IncomeCr
110563371,1675953576381-176-2841
Interest Expense
Interest ExpenseCr
248267227236226223212277272210232213
Depreciation
DepreciationCr
389415407405420425436455473515513547
PBT
PBTCr
2148083191,1469815648797171-68248128
Tax
TaxCr
425596284717527839-1649-9
PAT
PATCr
173753223862278145989133-52199137
Growth YoY
PAT Growth YoY%
111.13,739.1-46.2478.8-84.3-89.2106.1-89.7390.0-163.9-56.853.4
NPM
NPM%
5.019.15.725.10.82.110.42.33.1-1.24.43.1
EPS
EPS₹
1.15.51.15.5-0.10.22.90.30.71.10.80.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,3473,8914,1235,5146,3017,1438,18411,17414,75615,26216,92717,321
Growth
Revenue Growth%
8.316.26.033.714.313.414.636.532.03.410.99.8
Expenses
ExpensesCr
2,5802,9123,2944,1214,6975,4906,2148,66311,45712,09513,47213,785
Operating Profit
Operating ProfitCr
7689808291,3941,6031,6531,9702,5123,2993,1663,4553,536
OPM
OPM%
22.925.220.125.325.423.124.122.522.420.820.420.4
Other Income
Other IncomeCr
262173228340229188-105-837701,305-60-82
Interest Expense
Interest ExpenseCr
29266271655868419974897990927
Depreciation
DepreciationCr
2492773854485527158141,1131,5691,6871,9572,049
PBT
PBTCr
7518506101,2151,2151,0689838971,5251,887448479
Tax
TaxCr
1421621572123152222122542274577962
PAT
PATCr
6096884531,0039008467726431,2981,429369416
Growth
PAT Growth%
15.313.0-34.1121.3-10.3-6.0-8.8-16.7101.810.1-74.2-36.6
NPM
NPM%
18.217.711.018.214.311.89.45.88.89.42.22.4
EPS
EPS₹
4.75.23.17.76.36.25.43.98.68.52.83.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,3473,8914,1235,5146,3017,1438,18411,17414,75615,26216,92717,321
Growth
Revenue Growth%
8.316.26.033.714.313.414.636.532.03.410.99.8
Expenses
ExpensesCr
2,5802,9123,2944,1214,6975,4906,2148,66311,45712,09513,47213,785
Operating Profit
Operating ProfitCr
7689808291,3941,6031,6531,9702,5123,2993,1663,4553,536
OPM
OPM%
22.925.220.125.325.423.124.122.522.420.820.420.4
Other Income
Other IncomeCr
262173228340229188-105-837701,305-60-82
Interest Expense
Interest ExpenseCr
29266271655868419974897990927
Depreciation
DepreciationCr
2492773854485527158141,1131,5691,6871,9572,049
PBT
PBTCr
7518506101,2151,2151,0689838971,5251,887448479
Tax
TaxCr
1421621572123152222122542274577962
PAT
PATCr
6096884531,0039008467726431,2981,429369416
Growth
PAT Growth%
15.313.0-34.1121.3-10.3-6.0-8.8-16.7101.810.1-74.2-36.6
NPM
NPM%
18.217.711.018.214.311.89.45.88.89.42.22.4
EPS
EPS₹
4.75.23.17.76.36.25.43.98.68.52.83.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
100100300300600600600600600600811
Reserves
ReservesCr
3,9924,7384,8815,7986,1067,0277,83217,26719,18321,12233,329
Current Liabilities
Current LiabilitiesCr
1,6661,6782,1413,0394,0084,2103,8288,51115,35914,33414,069
Non Current Liabilities
Non Current LiabilitiesCr
2,4932,5022,2002,4473,0535,8057,09621,04315,43716,75112,960
Total Liabilities
Total LiabilitiesCr
8,4589,3949,99012,19214,44418,52220,39452,04356,07158,79763,651
Current Assets
Current AssetsCr
3,9714,0484,1494,8895,3257,6008,38212,33415,17916,28617,180
Non Current Assets
Non Current AssetsCr
4,4875,3475,8417,3049,11910,92212,01239,70940,89242,51146,471
Total Assets
Total AssetsCr
8,4589,3949,99012,19214,44418,52220,39452,04356,07158,79763,651
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
100100300300600600600600600600811
Reserves
ReservesCr
3,9924,7384,8815,7986,1067,0277,83217,26719,18321,12233,329
Current Liabilities
Current LiabilitiesCr
1,6661,6782,1413,0394,0084,2103,8288,51115,35914,33414,069
Non Current Liabilities
Non Current LiabilitiesCr
2,4932,5022,2002,4473,0535,8057,09621,04315,43716,75112,960
Total Liabilities
Total LiabilitiesCr
8,4589,3949,99012,19214,44418,52220,39452,04356,07158,79763,651
Current Assets
Current AssetsCr
3,9714,0484,1494,8895,3257,6008,38212,33415,17916,28617,180
Non Current Assets
Non Current AssetsCr
4,4875,3475,8417,3049,11910,92212,01239,70940,89242,51146,471
Total Assets
Total AssetsCr
8,4589,3949,99012,19214,44418,52220,39452,04356,07158,79763,651

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3716406621,1551,2831,1601,1771,8532,9544,0611,994
Investing Cash Flow
Investing Cash FlowCr
-1,142-499-684-714-1,559-3,625-1,699-14,282-1,005-234-2,082
Financing Cash Flow
Financing Cash FlowCr
1,068-178-240-2423882,56424213,049-2,333-1,854-924
Net Cash Flow
Net Cash FlowCr
297-36-26219911299-280619-3831,973-1,012
Free Cash Flow
Free Cash FlowCr
-24732-73-67-314-348-5192601,2971,925196
CFO To PAT
CFO To PAT%
60.893.0146.1115.2142.6137.1152.5288.1227.6284.1540.7
CFO To EBITDA
CFO To EBITDA%
48.365.379.982.880.070.259.773.889.5128.357.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3716406621,1551,2831,1601,1771,8532,9544,0611,994
Investing Cash Flow
Investing Cash FlowCr
-1,142-499-684-714-1,559-3,625-1,699-14,282-1,005-234-2,082
Financing Cash Flow
Financing Cash FlowCr
1,068-178-240-2423882,56424213,049-2,333-1,854-924
Net Cash Flow
Net Cash FlowCr
297-36-26219911299-280619-3831,973-1,012
Free Cash Flow
Free Cash FlowCr
-24732-73-67-314-348-5192601,2971,925196
CFO To PAT
CFO To PAT%
60.893.0146.1115.2142.6137.1152.5288.1227.6284.1540.7
CFO To EBITDA
CFO To EBITDA%
48.365.379.982.880.070.259.773.889.5128.357.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,64222,67035,65236,66032,47249,05640,16624,77431,70840,96458,49063,558
Price To Earnings
Price To Earnings
17.537.095.740.543.466.362.053.631.040.4151.6114.7
Price To Sales
Price To Sales
2.95.88.76.75.26.94.92.22.12.73.53.7
Price To Book
Price To Book
2.44.76.96.04.86.44.81.41.61.91.71.8
EV To EBITDA
EV To EBITDA
13.824.343.726.820.931.222.116.113.917.420.521.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
50.652.848.454.357.357.155.356.258.357.957.257.2
OPM
OPM%
22.925.220.125.325.423.124.122.522.420.820.420.4
NPM
NPM%
18.217.711.018.214.311.89.45.88.89.42.22.4
ROCE
ROCE%
11.912.49.516.314.79.37.73.76.97.02.92.9
ROE
ROE%
14.914.28.816.413.411.19.23.66.66.61.11.1
ROA
ROA%
7.27.34.58.26.24.63.81.22.32.40.60.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,64222,67035,65236,66032,47249,05640,16624,77431,70840,96458,49063,558
Price To Earnings
Price To Earnings
17.537.095.740.543.466.362.053.631.040.4151.6114.7
Price To Sales
Price To Sales
2.95.88.76.75.26.94.92.22.12.73.53.7
Price To Book
Price To Book
2.44.76.96.04.86.44.81.41.61.91.71.8
EV To EBITDA
EV To EBITDA
13.824.343.726.820.931.222.116.113.917.420.521.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
50.652.848.454.357.357.155.356.258.357.957.257.2
OPM
OPM%
22.925.220.125.325.423.124.122.522.420.820.420.4
NPM
NPM%
18.217.711.018.214.311.89.45.88.89.42.22.4
ROCE
ROCE%
11.912.49.516.314.79.37.73.76.97.02.92.9
ROE
ROE%
14.914.28.816.413.411.19.23.66.66.61.11.1
ROA
ROA%
7.27.34.58.26.24.63.81.22.32.40.60.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Biocon Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/xg9ia4rxr1u0116erlzevquk.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/oe34hhl5ti4mygsw4wk5lwx4.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/5i1v9bm4rayzostrlgq5xkui.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/cg6hwr0qs6wns4yst19880h2.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/40zt95j8trkbz03q8f1xgwgz.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/v15zprsqx4k5cv6skqa03q2f.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/t33tlqpqlrzsmfg318aju3gh.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/82x8aqfp2qz7qhako5tntvxu.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/9uc6imzuewpq00v6gis097rt.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/c6rv38b6amjmwn0rn81mzrn2.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/stclyeajlpyjrwywzralonzi.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/z2dym1rx4uho0p9glt3ox59k.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/n5mtbg4wm6uija6xsfu9nyob.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/6mr2vnjufabjybynjmtwkhdu.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/bosll8iphkt8wgv604bxl4e4.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ik15ab9xy15y4ohwkoid5scc.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/86dghwks9l99ldgb8f91jikp.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/pbjk71afdedxqecf5k2uhvxd.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/9euxk4glp7ajs6lbujeyslls.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/i85esgf367v0fguhwwe9lqe0.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/mlz63qwg9ga40yil1br5hbyx.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/ktrf38jka3gseztimlx1ut98.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/8r8ye31bokhexqjntqbt5sob.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/9yc0y5v4fw1zvo4cm4o589qu.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/eyb4tlhqj8gjibb8irgxdo5b.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ml4ex4hh8fmd0h8b2pggc079.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/34zdpcqhq8wphi4sds99cop6.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/4rhz6o60c3lank6vrr1lbnxi.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/wqm26eyfhjejfok43yz83qqp.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/3awt4a2htub7g7qivnz9tfvf.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/zres9pqf0ncgkslms33xjps6.pdf

Concall Transcript Summaries — Biocon Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202606/xg9ia4rxr1u0116erlzevquk.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202603/oe34hhl5ti4mygsw4wk5lwx4.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202512/5i1v9bm4rayzostrlgq5xkui.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202509/cg6hwr0qs6wns4yst19880h2.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202506/40zt95j8trkbz03q8f1xgwgz.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202503/v15zprsqx4k5cv6skqa03q2f.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202412/t33tlqpqlrzsmfg318aju3gh.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ABIOCON/transcript-notes/202409/82x8aqfp2qz7qhako5tntvxu.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies